Radiology / Nuclear Medicine

The Washington University physicians at Mallinckrodt Institute of Radiology (MIR) have been providing clinical radiology services for nearly three quarters of a century and have earned the reputation of a radiology leader.

MIR is a large and complex radiology department—a necessity for providing top quality radiology services to our patients.

Our expert radiologists, working with skilled nurses and technologists, perform and interpret more than 600,000 examinations and procedures each year. Combine this experience and expertise with productive research and training programs and you have a top-notch radiology facility for diagnosing and treating diseases.

Text Size: S M L

Home > Physicians Directory > Radiology / Nuclear Medicine

Farrokh Dehdashti, MD

Specialty Areas
Nuclear Medicine
Radiology
PET Imaging

Areas of Clinical Interest
Metabolic imaging, oncologic applications of PET imaging, receptor imaging in breast and prostate cancers, hypoxia imaging in various cancers, positron emission tomography

Major or Recent Publications/Awards

Honors and Awards

Listed in Best Doctors in America, 2003, 2005 - 2009 (Best Doctors, Inc)

Best Doctors in America (Midwest), 1996

Research Fellowship Award, Society of Nuclear Medicine Education and Research Foundation, Mallinckrodt Inc, 1989-1990

Editorial Responsibilities

Reviewer:
American Journal of Roentgenology
Annals of Thoracic Surgery
Journal of Nuclear Medicine
Journal of Pediatric Hematology and Oncology

Books and Book Chapters

Dehdashti F, Siegel BA. Estrogen-receptor imaging and assessing response to hormonal therapy of breast cancer. In: Price P, Shields A, eds. In Vivo Imaging of Cancer Therapy., in press

Dehdashti F, Siegel BA. Nuclear imaging of esophageal disorders. In Rice T, Patterson GA, eds. Pearson’s Esophageal Surgery, Philadelphia, Churchill Livingstone, in press

Lin LL, Dehdashti F, Siegel BA, Grigsby PW. PET and PET/CT of tumors of the female genital tract. In: von Schulthess GK, ed. Molecular Anatomic Imaging. PET-CT and SPECT-CT Integrated Modality Imaging, 2nd ed. Philadelphia, Lippincott Williams & Wilkins, 2007:427-442

Dehdashti F, Siegel BA. PET and PET/CT imaging in esophageal and gastric cancers. In: Valk PE, Delbeke D, Bailey DL, Townsend DW, Maisey MN, eds. Positron Emission Tomography. Clinical Practice. London, Springer-Verlag, 2006:165-180

Siegel BA, Dehdashti F. Oncologic PET/CT: current status and controversies. Eur Radiol 2005;15 Suppl 4:D127-32

Selected Journal Articles

Grigsby PW, Malyapa RS, Higashikubo SR, Schwarz JK, Welch MJ, Huettner PC, Dehdashti F. Comparison of Molecular Markers of Hypoxia and Imaging with (60)Cu-ATSM in Cancer of the Uterine Cervix. Mol Imaging Biol. 2007Apr 13; [Epub ahead of print]

Finkelstein SE, Fernandez FG, Dehdashti F, Siegel BA, Hawkins WG, Linehan DC, Strasberg SM. Unique site and time specific patterns of recurrence following resection of colorectal carcinoma hepatic metastases in patients staged by FDG-PET. J Hepatobiliary Pancreat Surg, in press

Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. The standardized uptake value for F-18 fluorodeoxyglucose (FDG) is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer, in press

Xue F, Lin LL, Dehdashti F, Miller T, Siegel BA, Grigsby PW. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gyn Oncol 2006; 101:147-151

Cotter SE, Grigsby PW, Siegel BA, Dehdashti F, Malyapa RS, Fleshman, Birnbaum, Wang X, Abbey E, Tan B, Kodner IJ, Hunt SR, Lowney JK, Mutch MG, Dietz DW, Myerson. FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phy 2006; 65:720-725

Biehl KJ, Kong FM, Dehdashti F, Jin JY, Mutic S, Naqa IE, Siegel BA, Bradley JD. 18F-FDG PET Definition of Gross Tumor Volume for Radiotherapy of Non-Small Cell Lung Cancer: Is a Single Standardized Uptake Value Threshold Approach Appropriate? J Nucl Med 2006; 47:1808-1812

Wright JD, Dehdashti F, Herzog TJ, Mutch DG, Huettner PC, Rader JS, Gibb RK, Powell MA, Gao F, Siegel BA, Grigsby PW. Preoperative nodal staging of early stage cervical carcinoma by FDG-PET. Cancer 2005; 104:2484-2491

Meyers BF, Downey RJ, Decker PA, Keenan RJ, Siegel BA, Cerfolio, Landreneau RJ, Reed CE, Balfe DM, Dehdashti F, Ballman KV, Rusch VW, Putnam JB Jr. The Utility of Positron Emission Tomography in Staging of Patients with Potentially Operable Carcinoma of the Thoracic Esophagus: Results of the American College of Surgeons Oncology Group Z-0060 Trial. Accepted for publication in J Thorac Cardiovasc Surg 2007; 133:738-745

Lamoreaux WT, Grigsby PW, Dehdashti F, Zoberi I, Powell MA, Gibb RK, Rader JS, Mutch DG, Siegel BA. FDG-PET evaluation of vaginal carcinoma. Int J Radiat Oncol Biol Phys 2005; 62(3):733-7

Laforest R, Dehdashti F, Lewis JS, Schwarz SW. Dosimetry of 60Cu-ATSM: a hypoxia imaging agent for PET. Eur J Nucl Med Mol Imaging 2005; 32:764-770

Grigsby PW, Mutch DG, Rader JS, Herzog TJ, Zoberi I, Siegel BA, Dehdashti F. Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. Int J Radiat Oncol Biol Phys 2005; 61:444-449

Dehdashti F, Picus J, Michalski JM, Dence CS, Siegel BA, Katzenellenbogen JA, Welch MJ. Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur J Nucl Med Mol Imaging 2005; 32:344-350

Battafarano R, Lee R, Patterson GA, Sundt T, Gutierrez F, Dehdashti F, Ritter J, Govindan R, Bradley J. Clinical-pathologic conference in general thoracic surgery: Cardiac lymphoma. J Thorac Cardiovasc Surg 2005; 130(3):870-874

Arslan N, Dehdashti F, Siegel BA. FDG uptake in colonic villous adenomas. Ann Nucl Med 2005 Jun; 19(4):331-334

Altay EE, Fessler AJ, Gallagher M, Attarian HP, Dehdashti F, Vahle VJ, Ojemann J, Dowling JL, Gilliam FG. Correlation of severity of FDG-PET hypometabolism and interictal regional delta slowing in temporal lobe epilepsy. Epilepsia 2005; 6:573-576

For more articles and abstracts, take this off-site link to the National Library of Medicine Pub Med page for Dr. Farrokh Dehdashti

Farrokh Dehdashti, MD